SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DaiS who wrote (13233)8/13/1998 5:21:00 PM
From: VLAD  Read Replies (2) of 23519
 
DaiS,

Don't quite understand this company. We all know the fundamentals behind the company and its product. We know that the ED market is barely tapped on a world wide basis and that Vivus will thrive even with orals such as Viagra.

The stock price has gone beyond absurd.

Unfortuneatly perception is the rule of the market and the perception is that there is not enough room for both MUSE and Viagra. MUSE scripts are down substantially but it still has only been about 3 months that Viagra has been available. IMO the next 3 months will tell us a lot regarding what exactly is going on in the ED market regarding these two drugs.

I just hope that Vivus doesn't end up as a hostile take over and we shareholders don't end up getting a lot less for our shares than we would have if more time was allowed to pass.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News